Senseera has closed a seed funding round, securing $7.1m to further develop its GEM BIOMARKERS liquid biopsy platform. Lightspeed Venture Partners led the financing round, with contributions from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback